Superparamagnetic iron oxide in the differential diagnosis of focal liver lesions at .5 T MRI;Ossido di ferro superparamagnetico nella diagnosi differenziale delle lesioni focali epatiche con apparecchio di risonanza magnetica da 0,5 tesla

Radiologia Medica

Volumn 95, Issue 6, 1998, Pages 593-598

  Di Cesare, Ernesto ^a,b   Cariello, Gianfranco ^a   Marchese, Francesco ^a   Michelini, Osvaldo ^b   Costanzi, Antonella ^a   Catalucci, Alessia ^a   Splendiani, Alessandra ^a   Masciocchi, Carlo ^a  

^a UNIVERSITY OF L'AQUILA   (Italy)

^b Ospedale S Maria di Collemaggio   (Italy)

Author keywords

Liver tumor, MRI; Liver tumor, SPIO; Liver, malignant lesions

Indexed keywords

SUPERPARAMAGNETIC IRON OXIDE;

ADULT; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; DIAGNOSTIC IMAGING; FEMALE; HUMAN; LIVER CANCER; LIVER TUMOR; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING;

CONTRAST MEDIA; DIAGNOSIS, DIFFERENTIAL; DRUG EVALUATION; FEMALE; FERROSOFERRIC OXIDE; HEMANGIOMA; HUMANS; IRON; LIVER NEOPLASMS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OXIDES; SENSITIVITY AND SPECIFICITY;

EID: 0031773478     PISSN: 00338362     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. Bellin MF, Zaim S, Auberton E e Coll: Liver metastases: safety and efficacy of detection with superparamagnetic iron oxide in MR Imaging. Radiology 193: 657-663, 1994.
2. Bellin MF, Zaim S. Auberton E e Coll: Efficacy of superparamagnetic iron oxide for the diagnosis of focal nodular hyperplasia, pag. S281 no 1405. Atti ECR '93, Vienna, 1993. Springer Verlag, Vienna. 1993.
3. Bernardino ME: Detection of liver lesions: CT-arterial portography vs contrast-enhanced CT and MRI. Contrast agents in liver imaging, pag. 45-49. Balzer T, Hamm B, Niendorf HP (Eds), Dordrecht, 1995.
4. Chambon C, Clement O, Le Blanche A e Coll: Superparamagnetic iron oxides as positive MR contrast agents: in vitro and in vivo evidence. Magnetic Resonance Imaging 11: 509-519, 1993.
5. Clement O, Frija G, Chambon C e Coll: Liver tumors in cirrhosis: experimental study with SPIO-enhanced MR Imaging. Radiology 180: 31-36, 1991.
6. Deckers F, Corthouts B, Nackaerts Y e Coll: The influence of MR field strength on the detection of focal liver lesions with superparamagnetic iron oxide Eur Radiol 7: 887-892, 1997.
7. Ferrucci JT, Stark DD: Iron oxide MR Imaging of the liver and spleen: review of the first 5 years. AJR 155: 943-950, 1990
8. Grangier C, Tourniaire J, Mentha G e Coll: Enhancement of liver hemangiomas on T1-weighted SE MR images by superparamagnetic iron oxide particles. JCAT 18: 888-896, 1994.
9. Hahn PF, Stark DD, Weissleder R e Coll: Clinical application of superparamagnetic iron oxide to MR Imaging of tissue perfusion in vascular liver tumors Radiology 174: 361-366, 1990.
10. Hammerstingl R, Vogl TJ, Schwarz W e Coll: Contrast-enhanced MRI using the superparamagnetic iron oxide AMI-25 in the differential diagnosis of focal liver lesions, pag. S171 no 859, Vienna, 1995. Atti ECR '95 Springer Verlag, Vienna. 1995
11. Hirohashi S, Kitano S, Ohmichi R e Coll: Superparamagnetic iron oxide enhanced magnetic resonance imaging of Kuppfer cell-containing tumors, pag. 1441. Atti XI Meeting Society Magnetic Resonance Medicine, Berlin 1992
12. Jonetz-Mentzel L, Kaiser WA: Characterization of focal liver lesions in MR Imaging by measurement of T1 and T2 relaxation times before and after application of SPIO, pag. s171 no 860. Atti ECR '95. Vienna, 1995. Springer Verlag, Vienna, 1995
13. Josephson L, Lewis J, Jacobs P e Coll: The effect of iron oxides on proton relaxivity Magn Resonance Imaging 6: 647-653, 1988.
14. Laniado M, Chachuat A: Vertraglichkeitsprofil von Endorem®. Radiologe 35 (suppl 2): 266-270. 1995.
15. Lencioni R, Laiolo E, Sbrana F e Coll: Detection of liver metastases: prospective comparison of unenhanced and superparamagnetic iron oxide-enhanced MRI. dual phase spiral CT, and spiral CT during arterial portography, pag. s71 no 353. Atti ECR '95, Vienna, 1995. Springer Verlag, Vienna, 1995
16. Marchai G, Ni Y. Potentials of new MRI contrast agents in the characterization of liver malignancies. Contrast agents in liver imaging, pag 59-66. Balzer T, Hamm B. NiendorfHP (Eds), Dordrecht, 1995.
17. Muller RD, Vogel K, Neumann F e Coll: MRI with superparamagnetic contrast agents versus double-spiral-CT in detecting malignant liver lesions, pag. s71 no 354 Atti ECR '95, Vienna, 1995. Springer Verlag, Vienna, 1995.
18. Pockler-Schoniger C, Koepke J, Guckel F e Coll: MR Imaging with superparamagnetic iron oxide particles: detection and characterization of malignant liver lesions, pag. s172 no 864 Atti ECR '95. Vienna, 1995. Springer Verlag, Vienna, 1995.
19. Reimer P, Rummeny EJ, Marx C e Coll: Characterization of focal liver lesions by means of enhancement on T2-W FSE MRI with the new SPIO Resovist: Results of a phase III study, pag. s171 no 862. Atti ECR '95, Vienna, 1995. Springer Verlag, Vienna, 1995
20. Reimer P, Rummeny EJ, Daldruo HE e Coll: Clinical results with Resovist a phase II clinical trial Radiology 195: 489-496, 1995.
21. Ros PR, Freeny PC, Harms SE e Coll: Hepatic MR Imaging with ferumoxides. a multicenter clinical trial of the safety and efficacy in the detection of focal hepatic lesions Radiology 196: 481-488, 1995.
22. Seneterre E, Gallix B. Taourel P e Coll: Tissue characterization with superparamagnetic irone oxide, signal intensity changes of hepatic nodules, pag. 107 Atti V ESGR '94, Taormina, 1994. Springer, 1994.
23. Seneterre E, Taourel P, Bouvier Y e Coll: Detection of hepatic metastases: ferumoxides-cnhanced MR Imaging versus unenhanced MR Imaging and CT during Arterial Portography. Radiology 200: 785-792, 1996.
24. Seneterre E, Vergnes C, Taourel P e Coll CT arterial portography (CTAP) versus superparamagnetic iron oxide MR Imaging for screening of hepatic metastases, pag. 403. Atti V ESGR '94, Taormina, 1994. Springer, 1994
25. Stiskal M, Huber S, Steibach R e Coll: Differentiation of benign and malignant liver tumors assessing MR Imaging enhanced with RES-contrast agent (Resovist). pag s171 no 861. Atti ECR '95, Vienna, 1995. Springer Verlag. Vienna, 1995.
26. Stoupis C, Ros PR, Gauger J e Coll: Superparamagnetic iron oxide enhanced MR Imaging vs CT arterial portography in detection of liver masses, pag 336. Atti V ESGR '94. Taormina, 1994. Springer, 1994.
27. Stoupis C, Ros PR, Marre S e Coll: Role of superparamagnetic iron oxide in characterization of benign liver masses MR Imaging-pathologic correlation, pag. 443 Atti XII Annual Scientific Meeting Society Magnetic Resonance Medicine, New York, 1993.
28. Vogl TJ, Hammerstingl R, Schwaetz W e Coll: Magnetic Resonance imaging of focal liver lesions. Comparison of the superparamagnetic iron oxide Resovist versus gadolinium-DTPA in the same patient Invest Radiol 31:696-708,1996.
29. Vogl TJ, Hammerstingl R, Assal J e Coll: Primary liver tumors: use of the superparamagnetic MRI-contrast agent AMI-25: in vivo-in vitro correlation, pag 104 no 235 Atti V ESGR '94, Taormina, 1994. Springer, 1994.
30. Vogl TJ, Hammerstingl R e Coll: Superparamagnetic iron oxide-enhanced versus Gadolinium-enhanced MR Imaging for differential diagnosis of focal liver lesions. Radiology 198: 881-887, 1996.
31. Weissleder R Liver MR Imaging with iron oxides toward consensus and clinical practice Radiology 193: 593-595, 1994.
32. Winter TC, Freeny PC, Nghiem HV e Coll: MR Imaging with superparamagnetic iron oxide: efficacy in the detection of focal hepatic lesions. AJR 161: 1191-1198, 1993.
33. Yamamoto H, Yamashjita Y, Yoshimatsu S e Coll: Hepatocellular carcinoma in cirrhotic livers: detection with unenhanced and iron oxide enhanced MR Imaging. Radiology 195. 106-112, 1995.
34. Yoshikawa K, Sasaki Y, Ogawa N c Coll: Clinical application of AMI-25 (superparamagnetic iron oxide) for the MR Imaging of hepatic tumors: a rnulticenter clinical phase III study. Nippon Acta Radiol 54: 137-153, 1994.